Terms: = Breast cancer AND CANT1, ENSG00000171302, 124583, Q8WVQ1, SHAPY, SCAN-1
13 results:
1. Pan-cancer analysis predicts cant1 as a potential prognostic, immunologic biomarker.
Yang W; Liu Z; Liu T
Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of cfDNA as an early detection assay for dense tissue breast cancer.
Barbirou M; Miller AA; Gafni E; Mezlini A; Zidi A; Boley N; Tonellato PJ
Sci Rep; 2022 May; 12(1):8458. PubMed ID: 35589867
[TBL] [Abstract] [Full Text] [Related]
3. [A Case of Primary Liposarcoma of Pancreas Difficult to Diagnose Preoperatively].
Suzuki A; Matsui H; Tokumitsu Y; Shindou Y; Matsukuma S; Nakajima M; Tomochika S; Yoshida S; Iida M; Suzuki N; Takeda S; Yoshino S; Hazama S; Nagano H
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1921-1923. PubMed ID: 33468873
[TBL] [Abstract] [Full Text] [Related]
4. Consensus on Contouring Primary breast Tumors on MRI in the Setting of Neoadjuvant Partial breast Irradiation in Trials.
Vasmel JE; Groot Koerkamp ML; Kirby AM; Russell NS; Shaitelman SF; Vesprini D; Anandadas CN; Currey A; Keller BM; Braunstein LZ; Han K; Kotte ANTJ; de Waard SN; Philippens MEP; Houweling AC; Verkooijen HM; van den Bongard HJGD
Pract Radiat Oncol; 2020; 10(6):e466-e474. PubMed ID: 32315784
[TBL] [Abstract] [Full Text] [Related]
5. The Predictive Value of Early Changes in
He M; Liu C; Shi Q; Sun Y; Zhang Y; Xu X; Yuan H; Zhang Y; Liu Y; Liu G; Di G; Yang Z; Wang Z; Shao Z
Oncologist; 2020 Nov; 25(11):927-936. PubMed ID: 32272493
[TBL] [Abstract] [Full Text] [Related]
6. Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case.
Stenman A; Hellgren LS; Jatta K; Hysek M; Zemmler M; Altena R; Nilsson IL; Bränström R; Zedenius J; Juhlin CC
Endocr Pathol; 2020 Mar; 31(1):77-83. PubMed ID: 32016808
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic performance of a novel dedicated breast PET scanner with C-shaped ring detectors.
Nakamoto R; Nakamoto Y; Ishimori T; Nishimatsu K; Miyake KK; Kanao S; Iima M; Toi M; Togashi K
Nucl Med Commun; 2017 May; 38(5):388-395. PubMed ID: 28306620
[TBL] [Abstract] [Full Text] [Related]
8. Assessment of Upfront Selection Criteria to Prioritise Patients for Breath-hold Left-sided breast Radiotherapy.
Tanna N; McLauchlan R; Karis S; Welgemoed C; Gujral DM; Cleator SJ
Clin Oncol (R Coll Radiol); 2017 Jun; 29(6):356-361. PubMed ID: 28139381
[TBL] [Abstract] [Full Text] [Related]
9. Measuring residual estrogen receptor availability during fulvestrant therapy in patients with metastatic breast cancer.
van Kruchten M; de Vries EG; Glaudemans AW; van Lanschot MC; van Faassen M; Kema IP; Brown M; Schröder CP; de Vries EF; Hospers GA
Cancer Discov; 2015 Jan; 5(1):72-81. PubMed ID: 25380844
[TBL] [Abstract] [Full Text] [Related]
10. Interaction of 11C-tariquidar and 11C-elacridar with P-glycoprotein and breast cancer resistance protein at the human blood-brain barrier.
Bauer M; Karch R; Zeitlinger M; Stanek J; Philippe C; Wadsak W; Mitterhauser M; Jäger W; Haslacher H; Müller M; Langer O
J Nucl Med; 2013 Aug; 54(8):1181-7. PubMed ID: 23833270
[TBL] [Abstract] [Full Text] [Related]
11. Scanning in situ spectroscopy platform for imaging surgical breast tissue specimens.
Krishnaswamy V; Laughney AM; Wells WA; Paulsen KD; Pogue BW
Opt Express; 2013 Jan; 21(2):2185-94. PubMed ID: 23389199
[TBL] [Abstract] [Full Text] [Related]
12. breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy.
Hattangadi J; Park C; Rembert J; Klifa C; Hwang J; Gibbs J; Hylton N
AJR Am J Roentgenol; 2008 Jun; 190(6):1630-6. PubMed ID: 18492917
[TBL] [Abstract] [Full Text] [Related]
13. Prospective correlative chemosensitivity testing in high-dose intraarterial chemotherapy for liver metastases.
Link KH; Aigner KR; Kuehn W; Schwemmle K; Kern DH
Cancer Res; 1986 Sep; 46(9):4837-40. PubMed ID: 3731130
[TBL] [Abstract] [Full Text] [Related]
